A COMPARATIVE STUDY ON EFFICACY AND ADVERSE EFFECTS OF ANTIMALARIAL...
Microalbuminuria Bose T
1. A STUDY ON MICROALBUMINURIA AS A PREDICTIVE MARKER OF TARGET ORGAN DAMAGE IN HYPERTENSION Dr. Tanoy Bose Co authors: Kalita HC, Laskar B, Gogoi GN, Baruah K, Kotokey D, Das K, Dutta A
2. Introduction Accurate cardiovascular risk evaluation: a prerequisite for devising cost-effective therapeutic strategies in patients with essential HTN. Microalbuminuria, an integrated marker of target organ damage and, therefore, of global risk, could prove to be a valuable tool in the screening and identification of hypertensive patients who are at higher cardiovascular risk. Evidence : Regression of left ventricular hypertrophy parallels the reduction of albuminuria to some degree regardless of BP changes.† †Olsen MH, Wachtell K, Borch-Johnsen K, Okin PM, Kjeldsen SE, Dahlof B, Devereux RB, Ibsen HA:. Losartan Intervention For Endpoint reduction. J Hum Hypertens 16: 591 595, 2002
3. Aims and Objectives Prevalence of microalbuminuria (MAU) among hypertensive patients Co-relationship of microalbuminuria with duration & severity of hypertension, sex, dyslipidemia and ceratin specific target organ damage due to hypertension
4. Methodology Non-randomized, cross-sectional, observational study. 128 cases of hypertension : JNC 7 criteria. Duration: 1 year from July 2005 to June 2006. Examined clinically, routinely investigated along with creatinine clearance, lipid profile, ophthalmoscopy, ECG and urine MAU estimation.